About this trial
The Urgency, Severity, and Impact Questionnaire (USIQ) assesses urinary urgency independently of incontinence, measuring both symptom severity and its impact on quality of life. While validated in English and Hebrew populations, a Turkish version has not yet been developed. This study aims to adapt USIQ for the Turkish population and evaluate its psychometric properties, providing a standardized, culturally relevant tool for clinical and research use.
Eligibility criteria
Qualifiers
Women aged 18-65 years
Able to read and write in Turkish
Diagnosed with overactive bladder (OAB) presenting with urgency (either wet or dry type)
Willing to sign the informed consent form after being informed about the study
Disqualifiers
Urinary tract infection symptoms or an active infection diagnosis within the past month
Neurological conditions causing neurogenic bladder such as multiple sclerosis, Parkinson's disease, stroke, or spinal cord injury
Cognitive impairment preventing comprehension and completion of the questionnaires
Post-void residual urine volume (PVR) exceeding 150 mL
Trial design
Treatments tested in this trial
- Observational Cohort